Healthcare provider profile · identity verified

Stephen Gerald Bell, M.D.

Internal Medicine · BIRMINGHAM, AL · NPI 1164749354

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	911	291
Amlodipine Besylate	Amlodipine Besylate	703	222
Losartan Potassium	Losartan Potassium	406	126
Levothyroxine Sodium	Levothyroxine Sodium	338	95
Trazodone Hcl	Trazodone Hcl	322	95
Hydrochlorothiazide	Hydrochlorothiazide	313	98
Gabapentin	Gabapentin	290	72
Pravastatin Sodium	Pravastatin Sodium	287	89
Rosuvastatin Calcium	Rosuvastatin Calcium	274	93
Omeprazole	Omeprazole	268	80
Lisinopril	Lisinopril	264	77
Pantoprazole Sodium	Pantoprazole Sodium	264	95
Tamsulosin Hcl	Tamsulosin Hcl	259	84
Metformin Hcl	Metformin Hcl	237	73
Eliquis	Apixaban	216	44
Allopurinol	Allopurinol	189	49
Metoprolol Succinate	Metoprolol Succinate	175	52
Furosemide	Furosemide	169	48
Carvedilol	Carvedilol	156	48
Metformin Hcl Er	Metformin Hcl	153	50
Metoprolol Tartrate	Metoprolol Tartrate	143	48
Tizanidine Hcl	Tizanidine Hcl	135	36
Simvastatin	Simvastatin	131	37
Ozempic	Semaglutide	130	22
Fluticasone Propionate	Fluticasone Propionate	128	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	127	33
Montelukast Sodium	Montelukast Sodium	123	31
Citalopram Hbr	Citalopram Hydrobromide	121	38
Atenolol	Atenolol	118	33
Zolpidem Tartrate	Zolpidem Tartrate	114	25
Albuterol Sulfate Hfa	Albuterol Sulfate	112	38
Sertraline Hcl	Sertraline Hcl	109	37
Tramadol Hcl	Tramadol Hcl	102	26
Duloxetine Hcl	Duloxetine Hcl	100	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	99	18
Mounjaro	Tirzepatide	93	13
Esomeprazole Magnesium	Esomeprazole Magnesium	91	26
Buspirone Hcl	Buspirone Hcl	89	23
Meloxicam	Meloxicam	89	28
Clonazepam	Clonazepam	84	15
Potassium Chloride	Potassium Chloride	84	25
Venlafaxine Hcl Er	Venlafaxine Hcl	82	27
Spironolactone	Spironolactone	79	22
Fluoxetine Hcl	Fluoxetine Hcl	78	18
Amitriptyline Hcl	Amitriptyline Hcl	77	19
Ezetimibe	Ezetimibe	75	26
Clopidogrel	Clopidogrel Bisulfate	73	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	21
Alprazolam	Alprazolam	70	19
Celecoxib	Celecoxib	68	18
Trulicity	Dulaglutide	67	13
Chlorthalidone	Chlorthalidone	62	20
Escitalopram Oxalate	Escitalopram Oxalate	61	23
Jardiance	Empagliflozin	60	19
Methocarbamol	Methocarbamol	60	21
Finasteride	Finasteride	58	17
Hydralazine Hcl	Hydralazine Hcl	58	17
Bupropion Xl	Bupropion Hcl	56	13
Glimepiride	Glimepiride	56	17
Triamcinolone Acetonide	Triamcinolone Acetonide	54	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	53	14
Januvia	Sitagliptin Phosphate	52	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	16
Azelastine Hcl	Azelastine Hcl	49	22
Warfarin Sodium	Warfarin Sodium	48	13
Famotidine	Famotidine	47	16
Mirtazapine	Mirtazapine	47	17
Valacyclovir	Valacyclovir Hcl	47	16
Glipizide Er	Glipizide	45	15
Paroxetine Hcl	Paroxetine Hcl	44	15
Ropinirole Hcl	Ropinirole Hcl	44	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	39	13
Alfuzosin Hcl Er	Alfuzosin Hcl	38	suppressed
Irbesartan	Irbesartan	38	12
Synthroid	Levothyroxine Sodium	38	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	13
Diclofenac Sodium	Diclofenac Sodium	37	19
Enalapril Maleate	Enalapril Maleate	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	11
Alendronate Sodium	Alendronate Sodium	35	13
Ondansetron Odt	Ondansetron	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Colchicine	Colchicine	33	suppressed
Lorazepam	Lorazepam	33	17
Primidone	Primidone	33	suppressed
Promethazine Hcl	Promethazine Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	12
Benazepril Hcl	Benazepril Hcl	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	25
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	30	suppressed
Ramipril	Ramipril	30	suppressed
Valsartan	Valsartan	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	23
Telmisartan	Telmisartan	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Estradiol	Estradiol	26	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	11
Ipratropium Bromide	Ipratropium Bromide	24	12
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Naproxen	Naproxen	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	22
Clonidine Hcl	Clonidine Hcl	22	suppressed
Fluconazole	Fluconazole	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Ketoconazole	Ketoconazole	21	18
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Prednisone	Prednisone	20	14
Terazosin Hcl	Terazosin Hcl	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Lactulose	Lactulose	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Azithromycin	Azithromycin	17	15
Cephalexin	Cephalexin	17	13
Famciclovir	Famciclovir	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Methylprednisolone	Methylprednisolone	17	13
Pregabalin	Pregabalin	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Mupirocin	Mupirocin	16	14
Temazepam	Temazepam	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Praluent Pen	Alirocumab	15	suppressed
Clonidine	Clonidine	14	suppressed
Indapamide	Indapamide	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Ciclopirox	Ciclopirox Olamine	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Wegovy	Semaglutide	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Diazepam	Diazepam	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Probenecid-Colchicine	Probenecid/Colchicine	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error